跳至主要内容
临床试验/NCT02202317
NCT02202317已完成不适用

Follow-up Yttrium-90 Internal Pair Production PET/CT Imaging in Patients With Primary or Metastatic Liver Tumors as Compared With Brehmsstrahlung Imaging: A Prospective Case Series

University of Miami1 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2013年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
9
试验地点
1
主要终点
Number of Subjects Whose Y-90 Based PET/CT (Positron Emission Tomography/Computed Tomography)Scans Detected Extrahepatic Non-target Embolization.

研究概览

简要总结

This is a prospective non-blinded case series involving the acquisition of a pair production PET/CT as soon as possible after an already performed Y-90 Sirspheres treatment of hepatic malignancy. It will be performed in addition to the standard Brehmsstrahlung SPECT scan. The sequence of the two scans in each case (PET/CT vs SPECT) will be determined by availability of the scanners at the time. However, it is intended that both be acquired on the day of the Y-90 treatment.

The length of subject participation will be one year.

The measures used will be mostly qualitative in nature, and will include:

  • Correlation with expected vs. achieved tumor coverage by the treatment
  • Correlation between treatment distribution depicted by Brehmsstrahlung scans vs. the Internal Pair Production PET/CT scans, to.
  • Detection of non-target embolization, where applicable, and qualitative comparison between the two modalities as to the conspicuity of the abnormality

Qualitative methods will be used by the analysis of the obtained PET/CT images and comparing them to the Brehmsstrahlung SPECT images as previously described.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Recipient of Selective Internal Radiation Treatment within 5 days.
  • •Anticipated ability to remain still for up to 40 minutes

排除标准

  • •Anticipated Inability to lie still for up to 40 minutes
  • •Severe claustrophobia
  • •Significant cardiovascular instability, or instability of other medical/surgical conditions, such that it would be deemed unsafe or technically not feasible to obtain a PET/CT, as determined by the any member of the investigative team
  • •Failed deployment of the planned Y-90 treatment for any reason
  • •Duration of time longer than 5 days since administration of the Y-90 treatment
  • •Known pregnancy

研究组 & 干预措施

Y90 Based PET/CT Scan

Experimental

干预措施: PET/CT Scan (Device)

结局指标

主要结局

Number of Subjects Whose Y-90 Based PET/CT (Positron Emission Tomography/Computed Tomography)Scans Detected Extrahepatic Non-target Embolization.

时间窗: 12 months

Number of participants with detected extrahepatic non-target embolization. A qualitative comparison between the two modalities (Y-90 PET/CT and Brehmsstrahlung SPECT) as to the conspicuity of the abnormality would have been conducted had any participant had that result.

次要结局

  • Comparison Between Treatment Distribution Depicted by Tc99mMAA (Technetium-99m Macroaggregated Albumin) Brehmsstrahlung Scans vs. the Internal Pair Production PET/CT Scans.(12 months)
  • Comparison of Y-90 PET/CT to Y90 SPECT(12 Months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jason Salsamendi

Associate Professor of Clinical

University of Miami

研究点 (1)

Loading locations...

相似试验